POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,428 | +26.8% | 24,969 | -6.2% | 0.03% | +25.9% |
| Q2 2023 | $46,850 | +1.1% | 26,619 | +77.0% | 0.03% | +12.5% |
| Q1 2023 | $46,324 | -42.8% | 15,040 | -1.5% | 0.02% | -44.2% |
| Q4 2022 | $80,934 | +37.2% | 15,270 | -2.4% | 0.04% | +38.7% |
| Q3 2022 | $59,000 | -3.3% | 15,650 | -33.0% | 0.03% | +3.3% |
| Q2 2022 | $61,000 | -49.6% | 23,370 | -12.7% | 0.03% | -33.3% |
| Q1 2022 | $121,000 | +68.1% | 26,770 | +152.1% | 0.04% | +87.5% |
| Q4 2021 | $72,000 | 0.0% | 10,620 | +2.7% | 0.02% | -7.7% |
| Q3 2021 | $72,000 | – | 10,345 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $7,605,000 | 1.52% |
| Privium Fund Management (UK) Ltd | 48,470 | $353,000 | 0.38% |
| Pentwater Capital Management LP | 4,967,227 | $36,211,000 | 0.37% |
| J. Goldman & Co LP | 301,391 | $2,197,000 | 0.11% |
| Perceptive Advisors | 787,745 | $5,743,000 | 0.08% |
| KNOTT DAVID M | 29,566 | $216,000 | 0.08% |
| Virtus ETF Advisers LLC | 23,082 | $168,000 | 0.07% |
| Altium Capital Management LP | 32,238 | $235,000 | 0.06% |
| Advisory Services Network, LLC | 268,290 | $1,956,000 | 0.06% |
| MCF Advisors LLC | 66,185 | $482,000 | 0.05% |